Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
H. J. Yang, Wei Wang, Zimin Chen, et al.
Nature (2020) Vol. 586, Iss. 7830, pp. 572-577
Open Access | Times Cited: 755

Showing 1-25 of 755 citing articles:

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Tyler N. Starr, Allison J. Greaney, Sarah K. Hilton, et al.
Cell (2020) Vol. 182, Iss. 5, pp. 1295-1310.e20
Open Access | Times Cited: 2000
Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1050
A systematic review of SARS-CoV-2 vaccine candidates
Yetian Dong, Tong Dai, Yujun Wei, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 538
A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome
Weiqi Hong, H. J. Yang, Zhenfei Bi, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 470
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
Liangwei Duan, Qianqian Zheng, Hongxia Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 403
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 392
Circular RNA vaccines against SARS-CoV-2 and emerging variants
Liang Qu, Zongyi Yi, Yong Shen, et al.
Cell (2022) Vol. 185, Iss. 10, pp. 1728-1744.e16
Open Access | Times Cited: 374
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection
Seyed Hamid Safiabadi Tali, Jason J. LeBlanc, Zubi Sadiq, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 335
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 331
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
Yingzhu Li, Rumiana Tenchov, Jeffrey Smoot, et al.
ACS Central Science (2021) Vol. 7, Iss. 4, pp. 512-533
Open Access | Times Cited: 316
COVID-19 in early 2021: current status and looking forward
Chengdi Wang, Zhoufeng Wang, Guangyu Wang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 305
Vaccine adjuvants: mechanisms and platforms
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 285
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
Xiancai Ma, Fan Zou, Fei Yu, et al.
Immunity (2020) Vol. 53, Iss. 6, pp. 1315-1330.e9
Open Access | Times Cited: 279
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Tiong Kit Tan, Pramila Rijal, Rolle Rahikainen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 248
Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Ioannis P. Trougakos, Κimon Stamatelopoulos, Evangelos Terpos, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 240
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
Ian A. McDonald, Sam M. Murray, Catherine J. Reynolds, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 232
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
Mimi Guebre‐Xabier, Nita Patel, Jing-Hui Tian, et al.
Vaccine (2020) Vol. 38, Iss. 50, pp. 7892-7896
Open Access | Times Cited: 228
Recombinant protein vaccines, a proven approach against coronavirus pandemics
Jeroen Pollet, Wen‐Hsiang Chen, Ulrich Strych
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 71-82
Open Access | Times Cited: 227
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 211
Cardiovascular Manifestations of COVID-19 Infection
Ajit Magadum, Raj Kishore
Cells (2020) Vol. 9, Iss. 11, pp. 2508-2508
Open Access | Times Cited: 203
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
Yin-Feng Kang, Cong Sun, Zhen Zhuang, et al.
ACS Nano (2021) Vol. 15, Iss. 2, pp. 2738-2752
Open Access | Times Cited: 191
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Zezhong Liu, Wei Xu, Shuai Xia, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 190
Adjuvants for Coronavirus Vaccines
Zhihui Liang, Haoru Zhu, Xin Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 181
Aptamer Blocking Strategy Inhibits SARS‐CoV‐2 Virus Infection
Miao Sun, Siwen Liu, Xinyu Wei, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 18, pp. 10266-10272
Open Access | Times Cited: 179
Page 1 - Next Page

Scroll to top